The store will not work correctly when cookies are disabled.
7-methyl-3-oxo-N-(3-thiomorpholinopropyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-sulfonamide
ID: ALA3397389
PubChem CID: 118726648
Max Phase: Preclinical
Molecular Formula: C16H23N3O4S2
Molecular Weight: 385.51
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc2c(cc1S(=O)(=O)NCCCN1CCSCC1)NC(=O)CO2
Standard InChI: InChI=1S/C16H23N3O4S2/c1-12-9-14-13(18-16(20)11-23-14)10-15(12)25(21,22)17-3-2-4-19-5-7-24-8-6-19/h9-10,17H,2-8,11H2,1H3,(H,18,20)
Standard InChI Key: SGVZBNKFGWFVIC-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
-4.9497 0.8990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9106 1.4992 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-4.9500 2.0989 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.2097 9.7510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5076 10.5030 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-7.8078 9.7550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8100 8.2550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5122 7.5029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2120 8.2510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5114 6.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2118 5.2515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2110 3.7506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9114 3.0001 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6321 1.3486 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6486 -1.3517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
4 9 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 2 1 0
2 14 1 0
14 15 2 0
15 19 1 0
18 16 1 0
16 17 2 0
17 14 1 0
18 19 2 0
18 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
21 24 2 0
17 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 385.51 | Molecular Weight (Monoisotopic): 385.1130 | AlogP: 1.04 | #Rotatable Bonds: 6 |
Polar Surface Area: 87.74 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.45 | CX Basic pKa: 7.40 | CX LogP: 0.54 | CX LogD: 0.23 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.71 | Np Likeness Score: -1.90 |
References
1. Konda S, Raparthi S, Bhaskar K, Munaganti RK, Guguloth V, Nagarapu L, Akkewar DM.. (2015) Synthesis and antimicrobial activity of novel benzoxazine sulfonamide derivatives., 25 (7): [PMID:25754493] [10.1016/j.bmcl.2015.01.026] |